0
0
6/7/23 at 3:38pm
Organization
Nature.com
26 words
0
Comments
Agonists of α2-adrenergic receptors could substantially improve the clinical efficacy of cancer immunotherapy.
You are the first to view
https://www.nature.com/articles/s41586-023-06110-8
Create an account
or login to join the discussion